Abstract
We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.
| Original language | Italian |
|---|---|
| Pages (from-to) | 211-213 |
| Number of pages | 3 |
| Journal | Bollettino - Lega Italiana contro l'Epilessia |
| Issue number | 121-122 |
| Publication status | Published - Jul 2003 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica : Studio multicentrico. / Montagninì, A.; Beccarìa, F.; Romeo, A.; Veggiottì, P.; Vìri, M.; Alfeì, E.; Capovilla, G.
In: Bollettino - Lega Italiana contro l'Epilessia, No. 121-122, 07.2003, p. 211-213.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Efficacia e tollerabilità del valproato chrono nelle epilessie a esordio in età pediatrica
T2 - Studio multicentrico
AU - Montagninì, A.
AU - Beccarìa, F.
AU - Romeo, A.
AU - Veggiottì, P.
AU - Vìri, M.
AU - Alfeì, E.
AU - Capovilla, G.
PY - 2003/7
Y1 - 2003/7
N2 - We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.
AB - We retrospectively studied all patients referred to three Epilepsy Centres affected by epilepsy occurring in paediatric age and selected 92 patients assuming sustained-release valproate. Our findings underline that VPA, even in extended release form, has good efficacy and safety. In some patients (poor compliance, childhood, adolescents) the single administration improves quality of life.
KW - Divalproex
KW - Epilepsy
KW - Sustained-Release
UR - http://www.scopus.com/inward/record.url?scp=1242272727&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1242272727&partnerID=8YFLogxK
M3 - Articolo
SP - 211
EP - 213
JO - Bollettino - Lega Italiana contro l'Epilessia
JF - Bollettino - Lega Italiana contro l'Epilessia
SN - 0394-560X
IS - 121-122
ER -